Moderna files quarterly report (10-Q) for the period ended Mar 31, 2026

Moderna filed its quarterly report on Form 10-Q with the SEC on May 1, 2026, 4:10 PM ET, covering the quarter ended Mar 31, 2026. It reports fiscal Q1 2026 results.

• Revenue: $389.0M (+260.2% from $108.0M a year earlier)
• Operating income: −$1.39B (vs −$1.05B a year earlier)
• Net income: −$1.34B (vs −$971.0M a year earlier)
• Diluted EPS: $-3.40 (vs $-2.52 a year earlier)
• Form 10-Q accepted by EDGAR May 1, 2026, 4:10 PM ET
• Accession number 0001682852-26-000060

SEC filing 10-Q · accession 0001682852-26-000060 · sec.gov ↗